Table 3.
FCRI-SF scores within AS subgroups.
| SUBGROUP | P | r | |||
|---|---|---|---|---|---|
| Age at diagnosis | < 60 years | 60–70 years | ≥ 70 years | ||
| No. of patients | 19 | 39 | 85 | ||
| FCRI-SF score (SD) | 13.3 (5.9) | 11.9 (6.1) | 10.0 (7.4) | 0.03 | - |
| Gender | Female | Male | |||
| No. of patients | 53 | 90 | |||
| FCRI-SF score (SD) | 11.0 (7.5) | 10.9 (6.6) | 0.896 | - | |
| Initial biopsy | Yes | No | |||
| No. of patients | 41 | 102 | |||
| FCRI-SF score (SD) | 12.3 (7.1) | 10.4 (6.9) | 0.147 | - | |
| ACCI score | Score ≤ 5 | Score > 5 | |||
| No. of patients | 64 | 79 | |||
| FCRI-SF score (SD) | 10.6 (6.2) | 11.2 (7.5) | 0.598 | 0.064 | |
| Follow-up time | ≤ 18 months | > 18 months | |||
| No. of patients | 72 | 71 | |||
| FCRI-SF score (SD) | 11.8 (7.1) | 10.1 (6.8) | 0.127 | -0.14 | |
| Tumour size at diagnosis | ≤ 12 mm | > 12 mm | |||
| No. of patients | 63 | 80 | |||
| FCRI-SF score (SD) | 10.5 (6.7) | 11.3 (7.2) | 0.512 | -0.025 | |
| Growth rate | ≤ 0.7 mm/year | > 0.7 mm/year | |||
| No. patients | 87 | 54 | |||
| FCRI-SF score (SD) | 11.1 (7.2) | 10.7 (6.6) | 0.754 | 0.011 | |
| Former cancer diagnosis | Never | Yes | |||
| No. patients | 78 | 65 | |||
| FCRI-SF score (SD) | 10.5 (6.2) | 11.5 (7.7) | 0.373 | - | |
FCRI-SF: Fear of Cancer Recurrence Inventory-Short Form; SD: standard deviation; ACCI: age-adjusted Charlson Comorbidity Index Score; AS: active surveillance.